Literature DB >> 2230648

Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor.

J Chihara1, J Plumas, V Gruart, J Tavernier, L Prin, A Capron, M Capron.   

Abstract

Interleukin 5 (IL-5) acts on eosinophil differentiation and activation, suggesting the existence of a membrane receptor for IL-5 on eosinophils. Here, we report that 125I-labeled recombinant human IL-5 bound, at 4 degrees C, to high affinity receptors on human eosinophils. The association constant was higher for hypodense eosinophils (1.93 x 10(9) M-1) than for normodense cells (0.39 x 10(9) M-1), with a closely related number of receptor sites per cell. No specific binding occurred on neutrophils. The specific binding of IL-5 was induced by overnight incubation at 37 degrees C of human eosinophils with granulocyte/macrophage (GM)-CSF. The levels of increase were significantly higher for normodense than for hypodense eosinophils, suggesting a previous in vivo activation of the later subpopulation by GM-CSF. IL-3 was ineffective by itself but synergistically enhanced the effect of GM-CSF. Specificity studies showed that the binding of 125I-labeled IL-5 was inhibited by IL-5, but not by other cytokines, on human eosinophils. These results show the existence of a specific binding site for IL-5 on human eosinophils with a variable affinity on eosinophil hypodense or normodense subpopulations, as previously reported for other membrane receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230648      PMCID: PMC2188662          DOI: 10.1084/jem.172.5.1347

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells.

Authors:  J W Lowenthal; B E Castle; J Christiansen; J Schreurs; D Rennick; N Arai; P Hoy; Y Takebe; M Howard
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

2.  Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins.

Authors:  H Saito; K Hatake; A M Dvorak; K M Leiferman; A D Donnenberg; N Arai; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes.

Authors:  M Capron; M D Kazatchkine; E Fischer; M Joseph; A E Butterworth; J P Kusnierz; L Prin; J P Papin; A Capron
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

4.  Expression of human and murine interleukin-5 in eukaryotic systems.

Authors:  J Tavernier; R Devos; J Van der Heyden; G Hauquier; R Bauden; I Fache; E Kawashima; J Vandekerckhove; R Contreras; W Fiers
Journal:  DNA       Date:  1989-09

5.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

Authors:  L Prin; J Charon; M Capron; P Gosset; H Taelman; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Variations in protein expression related to human eosinophil heterogeneity.

Authors:  V Gruart; J M Balloul; L Prin; M Tomassini; S Loiseau; A Capron; M Capron
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

8.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

Authors:  E J Clutterbuck; E M Hirst; C J Sanderson
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

10.  Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.

Authors:  S Mita; N Harada; S Naomi; Y Hitoshi; K Sakamoto; M Akagi; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

  10 in total
  17 in total

Review 1.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

2.  Eosinophils induce airway smooth muscle cell proliferation.

Authors:  Rabih Halwani; Alejandro Vazquez-Tello; Yuki Sumi; Mary Angeline Pureza; Ahmed Bahammam; Hamdan Al-Jahdali; Abdelillah Soussi-Gounni; Bassam Mahboub; Saleh Al-Muhsen; Qutayba Hamid
Journal:  J Clin Immunol       Date:  2012-11-23       Impact factor: 8.317

3.  Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation.

Authors:  A M Dvorak; S J Ackerman; T Furitsu; P Estrella; L Letourneau; T Ishizaka
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

4.  Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.

Authors:  R Sehmi; L J Wood; R Watson; R Foley; Q Hamid; P M O'Byrne; J A Denburg
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

5.  Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge.

Authors:  Mats W Johansson; Elizabeth A B Kelly; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.

Authors:  P C Tai; L Sun; C J Spry
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

Review 7.  The role of GM-CSF in infection.

Authors:  M Freund; H D Kleine
Journal:  Infection       Date:  1992       Impact factor: 3.553

8.  Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation.

Authors:  Steven G Smith; Mike Hill; John-Paul Oliveria; Brittany M Watson; Adrian J Baatjes; Benny Dua; Karen Howie; Heather Campbell; Rick M Watson; Roma Sehmi; Gail M Gauvreau
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

9.  Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

Authors:  P Desreumaux; A Janin; E Delaporte; S Dubucquoi; F Piette; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.

Authors:  K A Yamaoka; N Miyasaka; G Inuo; I Saito; J P Kolb; K Fujita; S Kashiwazaki
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.